MapLight Therapeutics, Inc.MPLT
Price (close)
$10.76
Market cap
$488.9M
P/E
—
Revenue (TTM)
—
Net income
-$229.8M
Dividend yield
—
1-year total return
—
Net margin
—
Revenue growth
—
Debt / equity
—
What MapLight Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net income | — | -$77.6M | -$161.2M |
| Free cash flow | — | -$79.6M | -$138.6M |
More on MPLT.
- MapLight Therapeutics, Inc. summary
- MapLight Therapeutics, Inc. financial statements
- MapLight Therapeutics, Inc. key metrics
- MapLight Therapeutics, Inc. health scores and style box
- MapLight Therapeutics, Inc. earnings
- MapLight Therapeutics, Inc. dividends
- MapLight Therapeutics, Inc. valuation
- MapLight Therapeutics, Inc. ownership and insiders
- MapLight Therapeutics, Inc. peers
Figures from MapLight Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.